NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
2022-11-08 $0.393 $0.404 $0.390 $0.400 590 176
2022-11-07 $0.408 $0.413 $0.381 $0.401 1 312 549
2022-11-04 $0.416 $0.423 $0.400 $0.421 864 378
2022-11-03 $0.402 $0.429 $0.400 $0.420 672 200
2022-11-02 $0.410 $0.426 $0.400 $0.414 1 181 174
2022-11-01 $0.400 $0.413 $0.396 $0.411 840 817
2022-10-31 $0.391 $0.420 $0.390 $0.412 711 552
2022-10-28 $0.410 $0.413 $0.392 $0.410 679 826
2022-10-27 $0.400 $0.419 $0.384 $0.409 2 403 931
2022-10-26 $0.365 $0.390 $0.365 $0.380 1 628 625
2022-10-25 $0.370 $0.389 $0.365 $0.389 5 475 549
2022-10-24 $0.378 $0.410 $0.354 $0.390 23 899 492
2022-10-21 $0.240 $0.245 $0.232 $0.240 357 563
2022-10-20 $0.240 $0.249 $0.232 $0.233 334 214
2022-10-19 $0.250 $0.250 $0.236 $0.237 424 101
2022-10-18 $0.255 $0.260 $0.240 $0.245 419 291
2022-10-17 $0.248 $0.250 $0.240 $0.243 321 460
2022-10-14 $0.250 $0.250 $0.236 $0.241 352 295
2022-10-13 $0.234 $0.250 $0.231 $0.235 771 840
2022-10-12 $0.241 $0.260 $0.230 $0.242 468 715
2022-10-11 $0.259 $0.263 $0.240 $0.240 552 671
2022-10-10 $0.280 $0.280 $0.254 $0.259 923 134
2022-10-07 $0.284 $0.284 $0.267 $0.275 585 852
2022-10-06 $0.273 $0.278 $0.260 $0.271 277 324
2022-10-05 $0.280 $0.282 $0.256 $0.263 661 653
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT